Advocate Lutheran General Hospital is a 645-bed non-profit teaching hospital located in the Chicago suburb of Park Ridge, Illinois. Founded in 1897, Advocate Lutheran General Hospital is the sixth largest hospital in the Chicago area, and it operates a Level I trauma center.

There are 645 beds in Advocate Lutheran General Hospital.

During the past decade, Advocate Lutheran General Hospital conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 50 clinical trials were completed, i.e. on average, 69.4% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 24 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advocate Lutheran General Hospital" #1 sponsor was "Children's Oncology Group" with 42 trials, followed by "National Cancer Institute (NCI)" with 40 trials sponsored, "Advocate Health Care" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored and "NRG Oncology" with 10 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advocate Lutheran General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 73 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Advocate Health Care" with 3 trials as a collaborator and "Alzheimer's Association" with 3 trials as a collaborator. Other collaborators include 76 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "Advocate Lutheran General Hospital" are "Breast Cancer" (7 trials), "Acute Lymphoblastic Leukemia" (5 trials), "Fallopian Tube Transitional Cell Carcinoma" (5 trials), "Invasive Breast Carcinoma" (5 trials) and "Ovarian Transitional Cell Carcinoma" (5 trials). Many other conditions were trialed in "Advocate Lutheran General Hospital" in a lesser frequency.

Most popular intervention types in "Advocate Lutheran General Hospital" are "Drug" (108 trials), "Other" (81 trials), "Biological" (41 trials), "Procedure" (39 trials) and "Radiation" (36 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (37 trials), "Quality-of-Life Assessment" (34 trials), "Questionnaire Administration" (24 trials), "Paclitaxel" (19 trials) and "Cyclophosphamide" (16 trials). Other intervention names were less common.

The vast majority of trials in "Advocate Lutheran General Hospital" are 136 trials for "All" genders, 30 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Advocate Lutheran General Hospital". undefined are not yet recruiting, 36 are recruiting, 48 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 70 completed trials in Advocate Lutheran General Hospital, 3 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Advocate Lutheran General Hospital, 5 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 89 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 23 trials that are defined as “Not Applicable".

Advocate Lutheran General Hospital has several departments that took part in Clinical trials: "Advocate Lutheran General Cancer Care Center" - 32 trials